Barclays’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $941K | Buy |
|
|||||
|
2025
Q1 | $512K | Sell |
|
|||||
|
2024
Q4 | $671K | Buy |
|
|||||
|
2024
Q3 | $593K | Buy |
|
|||||
|
2024
Q2 | $336K | Sell |
|
|||||
|
2024
Q1 | $588K | Sell |
|
|||||
|
2023
Q4 | $601K | Buy |
|
|||||
|
2023
Q3 | $77K | Buy |
|
|||||
|
2023
Q2 | $57K | Sell |
|
|||||
|
2023
Q1 | $130K | Buy |
|
|||||
|
2022
Q4 | $126K | Sell |
|
|||||
|
2022
Q3 | $211K | Sell |
|
|||||
|
2022
Q2 | $333K | Sell |
|
|||||
|
2022
Q1 | $448K | Buy |
|